PATENT CLAIM ANALYSIS

Application Number: 15890290
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["424", "134100"]

Abstract:
The present invention provides methods of administering Factor IX; methods of administering chimeric and hybrid polypeptides comprising Factor IX; polynucleotides encoding such chimeric and hybrid polypeptides; cells comprising such polynucleotides; and methods of producing such chimeric and hybrid polypeptides using such cells.

Claim (Index 124):
The method of  claim 122 , wherein each of the multiple doses is 25 IU/kg to 40 IU/kg.

Metadata:
- Claim Count in Document: 75.0
- Percentile: 88.0
- Lexical Diversity: 2.13636
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14982934', '15043457', '13809276', '15043445', '15890284']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8288158007444815
- 35 USC 102 Novelty (BERT): 0.7114045638144421
- Combined Prediction Score: 0.8170746770514775
- Mean Citation Score: 888.62134
- Max Citation Score: 906.3905
- Similarity Product: 745.8884590988159

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test